Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes

被引：1

作者：

Zepeda R. ^{[1
]}

Lee Y. ^{[1
]}

Agostini M. ^{[1
]}

Alick Lindstrom S. ^{[1
]}

Dave H. ^{[1
]}

Dieppa M. ^{[1
]}

Ding K. ^{[1
]}

Doyle A. ^{[1
]}

Harvey J. ^{[1
]}

Hays R. ^{[1
]}

Perven G. ^{[1
]}

Podkorytova I. ^{[1
]}

Das R.R. ^{[1
]}

机构：

[1] Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX

来源：

Neurodiagnostic Journal | 2021年 / 61卷 / 02期

关键词：

COVID-19; emergent admission; epilepsy monitoring unit (EMU); epileptic seizures (ES); psychogenic non-epileptic seizures (PNES);

D O I：

10.1080/21646821.2021.1918512

中图分类号：

学科分类号：

摘要：

Due to the coronavirus disease 2019 (COVID-19) pandemic, the state of Texas-limited elective procedures to conserve beds and personal protective equipment (PPE); therefore, between March 22 and May 18, 2020, admission to the epilepsy monitoring unit (EMU) was limited only to urgent and emergent cases. We evaluated clinical characteristics and outcomes of these patients who were admitted to the EMU. Nineteen patients were admitted (one patient twice) with average age of 36.26 years (11 female) and average length of stay 3 days (range: 2–9 days). At least one event was captured on continuous EEG (cEEG) and video monitoring in all 20 admissions (atypical in one). One patient had both epileptic (ES) and psychogenic non-epileptic seizures (PNES) while 10 had PNES and 9 had ES. In 8 of 9 patients with ES, medications were changed, while in 5 patients with PNES, anti-epileptic drugs (AED) were stopped; the remaining 5 were not on medications. Of the 14 patients who had seen an epileptologist pre-admission, 13 (or 93%) had their diagnosis confirmed by EMU stay; a statistically significant finding. While typically an elective admission, in the setting of the COVID-19 pandemic, urgent and emergent EMU admissions were required for increased seizure or event frequency. In the vast majority of patients (13 of 19), admission lead to medication changes to either better control seizures or to change therapeutics as appropriate when PNES was identified. © 2021 ASET–The Neurodiagnostic Society.

引用

页码：95 / 103

页数：8

共 17 条

[11]

Leung W.C.Y., Lau E.H.Y., Kwan P., Chang R.S., Impact of COVID-19 on seizure-related emergency attendances and hospital admissions - A territory-wide observational study, Epilepsy Behav, 115, (2021)

[12]

Parnell K.J., Cascino G.D., So E.L., Cicora K., Long-term EEG monitoring in patients with spells: clinical characteristics and predictive factors, Neurology, 52, 6, pp. A371-A2, (1999)

[13]

Parthasarathy P., Vivekanandan S., An extensive study on the COVID-19 pandemic, an emerging global crisis: risks, transmission, impacts and mitigation, J Infect Public Health, 14, 2, pp. 249-259, (2020)

[14]

Shih J.J., Fountain N.B., Herman S.T., Bagic A., Lado F., Arnold S., Zupanc M.L., Riker E., Labiner D.M., Indications and methodology for video-electroencephalographic studies in the epilepsy monitoring unit, Epilepsia, 59, 1, pp. 27-36, (2018)

[15]

Syed T.U., LaFrance W.C., Loddenkemper T., Benbadis S., Slater J.D., El-Atrache R., AlBunni H., Khan M.T., Aziz S., Ali N.Y., Et al., Outcome of ambulatory video-EEG monitoring in a ˜10,000 patient nationwide cohort, Seizure, 66, pp. 104-111, (2019)

[16]

(2020)

[17]

CMS releases recommendations on adult elective surgeries, non-essential medical, surgical, and dental procedures during COVID-19, (2020)

← 1 2 →